Analytical Tools for Biologics Molecular Assessment
Bibliographic record
Abstract
A variety of biotherapeutic moieties to treat various maladies including cancer, auto-immunity, and infectious diseases are currently in development or the clinic (Walsh G (2014) Biopharmaceutical benchmarks 2014. Nature biotechnology 32(10):992–1000). Biotechnological and pharmaceutical companies compete to produce either “first in class” or “best in class” biologics for safe and efficacious treatments (Thayer AM (2013) Biobetters may be a better bet. Chemical and engineering news 91:24–25). In a typical workflow, panels of antibodies or other proteins are generated against an antigen of interest whereby each may have similar binding potential and efficacy. To decipher which of several candidate molecules should be promoted as the lead candidate, several analytical procedures are undertaken to assess the stability and durability of a molecule. This allows biotherapeutics to be tested for their ability to remain stable during the expression, production, and patient delivery processes. It also allows biopharma to generate information regarding technical liabilities and to assess if any physicochemical properties need to be further optimized for sustained shelf-life and safer in vivo delivery. Molecular assessment along with the potency and pharmacodynamic and pharmacokinetic properties of a molecule all determine its suitability as a lead candidate for a first or best in class molecular moiety.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.004 | 0.006 |
| Meta-epidemiology (narrow) | 0.002 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.007 | 0.003 |
| Science and technology studies | 0.001 | 0.002 |
| Scholarly communication | 0.003 | 0.004 |
| Open science | 0.002 | 0.003 |
| Research integrity | 0.002 | 0.004 |
| Insufficient payload (model declined to judge) | 0.017 | 0.017 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".